Wall Street Slips as Tech Stocks Slide on AI Spending Fears and Earnings Concerns 
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 
U.S. Eases Venezuela Oil Sanctions to Boost American Investment After Maduro Ouster 
DOJ Sues Virginia Over Failure to Provide Full Voter Registration Records 
U.S. Dollar Slides for Second Week as Tariff Threats and Iran Tensions Shake Markets 
South Korea Industry Minister Heads to Washington Amid U.S. Tariff Hike Concerns 
Asian Stocks Waver as Trump Signals Fed Pick, Shutdown Deal and Tech Earnings Stir Markets 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
Asia Stocks Pause as Tech Earnings, Fed Signals, and Dollar Weakness Drive Markets 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Federal Judge Rules Trump Administration Unlawfully Halted EV Charger Funding 
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation 
Former South Korean President Yoon Suk Yeol Faces Historic Court Ruling Over Failed Martial Law Attempt 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
Supreme Court Signals Doubts Over Trump’s Bid to Fire Fed Governor Lisa Cook 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
Trump Threatens 50% Tariff on Canadian Aircraft Amid Escalating U.S.-Canada Trade Dispute 
Johnson & Johnson offered $8.9 billion to settle years-old lawsuits claiming that its talcum powder products caused cancer.
The New Jersey-based pharmaceutical giant described their proposal, which still needs a bankruptcy court’s approval, as an equitable and efficient resolution to all claims arising from cosmetic talc litigation.
If approved by the bankruptcy court and a majority of the claimants, the $8.9 billion deal would rank alongside those reached by cigarette corporations and opioid producers as one of the largest product liability settlements ever in the US
Thousands of claims have been filed against J&J because of talcum powder that may have contained traces of asbestos and was linked to ovarian cancer.
The company has never acknowledged wrongdoing, but as of May 2020, it no longer sells its talc-based baby powder in the US and Canada.
The $8.9 billion would be paid to the tens of thousands of claimants over 25 years through a J&J subsidiary, LTL Management LLC, which was set up to address the claims and has filed for bankruptcy protection.
A previous settlement involving LTL was rejected by an appellate court.
